000 | 02140 a2200541 4500 | ||
---|---|---|---|
005 | 20250517113028.0 | ||
264 | 0 | _c20170323 | |
008 | 201703s 0 0 eng d | ||
022 | _a1873-3441 | ||
024 | 7 |
_a10.1016/j.ejpb.2016.08.013 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSarisozen, Can | |
245 | 0 | 0 |
_aNanomedicine based curcumin and doxorubicin combination treatment of glioblastoma with scFv-targeted micelles: In vitro evaluation on 2D and 3D tumor models. _h[electronic resource] |
260 |
_bEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V _cNov 2016 |
||
300 |
_a54-67 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 | _aBiotinylation |
650 | 0 | 4 | _aBlood-Brain Barrier |
650 | 0 | 4 |
_aCell Line, Tumor _xdrug effects |
650 | 0 | 4 |
_aCurcumin _xadministration & dosage |
650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
650 | 0 | 4 |
_aDrug Carriers _xchemistry |
650 | 0 | 4 |
_aDrug Delivery Systems _xmethods |
650 | 0 | 4 | _aDrug Evaluation, Preclinical |
650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 |
_aGlioblastoma _xmetabolism |
650 | 0 | 4 |
_aGlucose Transporter Type 1 _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLigands |
650 | 0 | 4 | _aMicelles |
650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
650 | 0 | 4 |
_aNanomedicine _xmethods |
650 | 0 | 4 |
_aNeoplasms _xpathology |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 | _aPolymers |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aSingle-Chain Antibodies _xchemistry |
650 | 0 | 4 | _aSpheroids, Cellular |
700 | 1 | _aDhokai, Shekhar | |
700 | 1 | _aTsikudo, Edcar G | |
700 | 1 | _aLuther, Ed | |
700 | 1 | _aRachman, Ilya M | |
700 | 1 | _aTorchilin, Vladimir P | |
773 | 0 |
_tEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V _gvol. 108 _gp. 54-67 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejpb.2016.08.013 _zAvailable from publisher's website |
999 |
_c26367471 _d26367471 |